CHILDREN’S MEDICINES
March 1st, 2002
BY KEITH NUTHALLINCENTIVES designed to encourage European pharmaceutical manufacturers to develop specialist children's medicines have been proposed by the European Commission; its consultation paper also suggests ways of increasing the testing of existing general medicines for their effectiveness and safety regarding young patients.Brussels has suggested that a longer period of intellectual property protection could be established for innovative children's medicines, and a new type of marketing authorisation, giving intellectual property rights to new paediatric ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.